Matches in Nanopublications for { ?s ?p "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP575677.RAbl-0OhgMFmjesydYJ8Tb_1cLf3Z92A36Yo7ueP4Qy7c130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575677.RAbl-0OhgMFmjesydYJ8Tb_1cLf3Z92A36Yo7ueP4Qy7c130_provenance.
- NP714848.RATvy7bP816ccmkieA-kVVsDVRW-ORd9VzLM2B8ugFgnM130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714848.RATvy7bP816ccmkieA-kVVsDVRW-ORd9VzLM2B8ugFgnM130_provenance.
- NP467413.RAorPackOVg0S58OPsslcPHJmCc60xdBm6L9V9hk7JfaY130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467413.RAorPackOVg0S58OPsslcPHJmCc60xdBm6L9V9hk7JfaY130_provenance.
- NP562808.RAgRNS-ITmY6ukaaUJBVokv7e0RLr--S-9FopQCgPah08130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562808.RAgRNS-ITmY6ukaaUJBVokv7e0RLr--S-9FopQCgPah08130_provenance.
- NP601613.RAvxP2wY5hmgW-xbzqtUvWH_ruChspb7sbe8l9Pkku3uQ130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601613.RAvxP2wY5hmgW-xbzqtUvWH_ruChspb7sbe8l9Pkku3uQ130_provenance.
- NP254971.RAV4PpLah-7U-he3Rig6-j8zPkuyg32mrtre2bjYDgkck130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254971.RAV4PpLah-7U-he3Rig6-j8zPkuyg32mrtre2bjYDgkck130_provenance.
- NP923533.RAqVRQjRhO_cPzxqC1ItED8-g-5qs-UbtdKjmp2uKhms0130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923533.RAqVRQjRhO_cPzxqC1ItED8-g-5qs-UbtdKjmp2uKhms0130_provenance.
- NP914870.RAE9kuGX4ZEmaTy2pmnjtXc3kRltJQTNKk_1egQqQau-o130_assertion description "[The most common gains in anaplastic carcinoma were in chromosomes 7p (p22-pter, 31%), 8q (q22-qter, 23%), and 9q (q34-qter, 23%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914870.RAE9kuGX4ZEmaTy2pmnjtXc3kRltJQTNKk_1egQqQau-o130_provenance.